Milstein gets Vice President role at Cardio3

Belgian biotechnology company, Cardio3 BioSciences, a developer of regenerative and protective therapies for the treatment of cardiac diseases, has appointed Dr Alexander Milstein to the position of Vice President of Clinical Development. Milstein will lead the clinical development programme for C3BS-CQR-1, which is due to enter Phase III later in 2012, as well as advancing the company's other products into clinical development. Prior to joining Cardio3, Milstein held the position of Vice President, Clinical Development at Cytori Therapeutics.

Milstein gets Vice President role at Cardio3

Belgian biotechnology company, Cardio3 BioSciences, a developer of regenerative and protective therapies for the treatment of cardiac diseases, has appointed Dr Alexander Milstein to the position of Vice President of Clinical Development. Milstein will lead the clinical development programme for C3BS-CQR-1, which is due to enter Phase III later in 2012, as well as advancing the company's other products into clinical development. Prior to joining Cardio3, Milstein held the position of Vice President, Clinical Development at Cytori Therapeutics.

×

Enter your details to read the full article

By submitting this form you are acknowledging that you have read and understood our Privacy Policy.

×

REQUEST A DEMO

By submitting this form you are acknowledging that you have read and understood our Privacy Policy.

Thank you for your interest

A member of the team will be in touch shortly to arrange a convenient time for your free demonstration and trial. If your enquiry is urgent, please email our Client Services team here.